We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Read MoreHide Full Article
Key Takeaways
CYH completed the $110M sale of four Arkansas hospitals and related care facilities on June 1.
Community Health is using asset sales to enhance liquidity, reduce debt and focus on higher-growth areas.
CYH's long-term debt declined to $10.13B in Q1 2026 from $11.43B at the end of 2024.
Community Health Systems, Inc. (CYH - Free Report) has completed the sale of four Arkansas hospitals to nonprofit Freeman Health System for $110 million. The transaction includes Northwest Medical Center–Bentonville, Northwest Medical Center–Springdale, Northwest Medical Center–Willow Creek Women's Hospital and Siloam Springs Regional Hospital, along with their related outpatient centers and physician practices. The agreement was announced in March 2026 and closed on June 1, 2026.
The Arkansas divestiture is part of CYH’s broader portfolio optimization strategy. In recent months, the hospital operator has completed several significant asset sales, including its majority stake in Tennova Healthcare-Clarksville for approximately $623 million, and the sale of Crestwood Medical Center and related facilities for roughly $459 million. These transactions have generated substantial proceeds, strengthening the company’s liquidity position and supporting ongoing debt-reduction efforts.
Community Health carries more than $10 billion in debt, making deleveraging a key strategic priority. Its debt-to-capital of 113.7% remains significantly above the industry average of 74.7%, while its debt-to-EBITDA ratio of 7.3X compares unfavorably with the industry norm of 3.7X. Through the sale of non-core assets, CYH is generating capital to strengthen its balance sheet and focus on higher-growth businesses such as outpatient care, ambulatory surgery centers and physician networks. Recent divestitures have supported this effort, with long-term debt declining to $10.13 billion in the first quarter of 2026 from $11.43 billion at the end of 2024.
Although hospital sales may create some near-term pressure on revenues, the broader objective is to streamline operations and concentrate resources on areas with stronger growth prospects. If management continues to execute on this strategy, CYH may improve profitability and build a more focused healthcare portfolio over time.
CYH’s Stock Price Performance
Shares of Community Health have declined 11.9% year to date, faring better than the industry’s 18.2% fall.
Image Source: Zacks Investment Research
CYH’s Zacks Rank & Key Picks
Community Health currently carries a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.47 per share, indicating a 66.8% year-over-year increase. CNC beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 74.9%. The consensus estimate for 2026 revenues is pinned at $191.03 billion.
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 23 cents per share, which has witnessed two upward revisions in the past 30 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.42 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Hinge Health’s 2026 earnings is pegged at $2.51 per share, which has moved up 65 cents over the past 30 days. The consensus estimate for revenues is pegged at $801.61 million, indicating 36.4% year-over-year growth. HNGE’s bottom line surpassed estimates in each of the trailing four quarters, the average surprise being 179.54%.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
CYH Completes Sale of Four Arkansas Hospitals for $110M to Lower Debt
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) has completed the sale of four Arkansas hospitals to nonprofit Freeman Health System for $110 million. The transaction includes Northwest Medical Center–Bentonville, Northwest Medical Center–Springdale, Northwest Medical Center–Willow Creek Women's Hospital and Siloam Springs Regional Hospital, along with their related outpatient centers and physician practices. The agreement was announced in March 2026 and closed on June 1, 2026.
The Arkansas divestiture is part of CYH’s broader portfolio optimization strategy. In recent months, the hospital operator has completed several significant asset sales, including its majority stake in Tennova Healthcare-Clarksville for approximately $623 million, and the sale of Crestwood Medical Center and related facilities for roughly $459 million. These transactions have generated substantial proceeds, strengthening the company’s liquidity position and supporting ongoing debt-reduction efforts.
Community Health carries more than $10 billion in debt, making deleveraging a key strategic priority. Its debt-to-capital of 113.7% remains significantly above the industry average of 74.7%, while its debt-to-EBITDA ratio of 7.3X compares unfavorably with the industry norm of 3.7X. Through the sale of non-core assets, CYH is generating capital to strengthen its balance sheet and focus on higher-growth businesses such as outpatient care, ambulatory surgery centers and physician networks. Recent divestitures have supported this effort, with long-term debt declining to $10.13 billion in the first quarter of 2026 from $11.43 billion at the end of 2024.
Although hospital sales may create some near-term pressure on revenues, the broader objective is to streamline operations and concentrate resources on areas with stronger growth prospects. If management continues to execute on this strategy, CYH may improve profitability and build a more focused healthcare portfolio over time.
CYH’s Stock Price Performance
Shares of Community Health have declined 11.9% year to date, faring better than the industry’s 18.2% fall.
Image Source: Zacks Investment Research
CYH’s Zacks Rank & Key Picks
Community Health currently carries a Zacks Rank #3 (Hold).
Some top-ranked stocks in the broader Medical space are Centene Corporation (CNC - Free Report) , Surgery Partners, Inc. (SGRY - Free Report) and Hinge Health, Inc. (HNGE - Free Report) , each sporting a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Centene’s 2026 earnings is pegged at $3.47 per share, indicating a 66.8% year-over-year increase. CNC beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 74.9%. The consensus estimate for 2026 revenues is pinned at $191.03 billion.
The Zacks Consensus Estimate for Surgery Partners’ 2026 earnings is pegged at 23 cents per share, which has witnessed two upward revisions in the past 30 days, with no movement in the opposite direction. The consensus estimate for SGRY’s 2026 revenues is pinned at $3.42 billion, implying 3.4% year-over-year growth.
The Zacks Consensus Estimate for Hinge Health’s 2026 earnings is pegged at $2.51 per share, which has moved up 65 cents over the past 30 days. The consensus estimate for revenues is pegged at $801.61 million, indicating 36.4% year-over-year growth. HNGE’s bottom line surpassed estimates in each of the trailing four quarters, the average surprise being 179.54%.